NeuroSpectrum Insights, Inc. (NSIH)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	66.64M
Revenue (ttm)	n/a
Net Income	-1.83M
EPS	-0.12
Shares Out	14.81M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NSIH

NeuroSpectrum Insights is a medical device company preparing to commercialize breakthrough computerized analysis technology that enhances clinicians’ capabilities in diagnosing neurological and neurodevelopmental disorders. NSI’s first product, GyriCalc™ is a proprietary, patented software solution specifically designed to assist in the diagnosis of autism by identifying early structural markers of neurodevelopmental differences through the automated measurement and analysis of MRI images. NSI’s initial market focus will be the United States an...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 2
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: NSIH

Financial Performance

Data Source: SEC filings Last updated: Aug 20, 2026

The data for this page was gathered manually by the Stock Analysis team, from official company filings available on SEC.gov.

Data Sources Report a data error